Changeflow GovPing Healthcare & Life Sciences Multiple Antihypertensives Increase Post-Induct...
Routine Notice Added Final

Multiple Antihypertensives Increase Post-Induction Hypotension Risk in Cardiac Surgery

Favicon for changeflow.com ClinicalTrials.gov Studies
Detected
Email

Summary

NIH has registered observational study NCT07541222 investigating whether preoperative use of multiple antihypertensive drug classes increases post-induction hypotension burden in cardiac surgery patients. Researchers will observe whether combinations of ACE inhibitors, ARBs, beta-blockers, and calcium channel blockers correlate with higher incidence and severity of blood pressure drops and increased vasoactive support needs between anesthesia induction and surgical incision.

“The researchers will observe whether the combination of different antihypertensive classes (such as ACE inhibitors, ARBs, beta-blockers, and calcium channel blockers) leads to a higher incidence and severity of blood pressure drops and increased need for vasoactive support during the period between anesthesia induction and surgical incision.”

NIH , verbatim from source
Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

NIH has registered a new observational clinical study, NCT07541222, on ClinicalTrials.gov. The study examines whether preoperative use of multiple antihypertensive medication classes increases the burden of post-induction hypotension in patients undergoing elective cardiac surgery.

Clinical investigators and cardiac surgery programs should note this research may inform perioperative medication management protocols. The study focuses on combinations of ACE inhibitors, ARBs, beta-blockers, and calcium channel blockers and their association with blood pressure instability requiring vasoactive support.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

The Impact of Multiple Antihypertensive Therapy on Post-Induction Hypotension Burden in Cardiac Surgery Patients

Observational NCT07541222 Kind: OBSERVATIONAL Apr 21, 2026

Abstract

This study aims to investigate the impact of multiple preoperative antihyperstensive drug use on the burden of post-induction hypotension (PIH) in patients undergoing elective cardiac surgery. The researchers will observe whether the combination of different antihypertensive classes (such as ACE inhibitors, ARBs, beta-blockers, and calcium channel blockers) leads to a higher incidence and severity of blood pressure drops and increased need for vasoactive support during the period between anesthesia induction and surgical incision.

Conditions: Hypotension on Induction, Cardiac Surgery, Antihypertensive Agents, Anesthesia, Intravenous, Hemodynamics

Interventions: Chronic Antihypertensive Medication Use

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Clinical investigators Healthcare providers
Industry sector
6211 Healthcare Providers
Activity scope
Clinical research Drug therapy monitoring
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!